Detalhe da pesquisa
1.
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 74(7): 1268-1270, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293114
2.
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department.
J Clin Microbiol
; 60(3): e0239021, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35044204
3.
High level of HIV viral suppression in a cross-sectional study of Ugandan men with urethritis and bacterial STI.
Int J STD AIDS
; 34(14): 998-1003, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544771
4.
Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.
AIDS
; 36(9): 1315-1317, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833684
5.
SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.
JCI Insight
; 7(10)2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35389888
6.
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
medRxiv
; 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169815
7.
Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.
PLoS One
; 17(6): e0264298, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679259
8.
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern.
Blood Adv
; 6(12): 3678-3683, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443020
9.
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern.
medRxiv
; 2022 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262085
10.
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department.
medRxiv
; 2021 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671778